Saturday, August 13, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

by Medical Finance
in News
Scientists identify a new switch for controlling motor proteins
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A new study shows how mutation of the ADAR1 gene sets off biochemical pathways that produce an autoimmune response that harms the developing brain and other areas of the body.

The ADAR gene contains instructions for making proteins used by the immune system. Normally, the body’s immune system fights off pathogens, foreign bodies, and cancers. An RNA-editing enzyme produced by the ADAR1 gene steps in to stop abnormal immune activation when the body misidentifies its own RNA.

Mutations in the ADAR1 gene are common in people of northern European descent. When a second specific mutation is also present in an individual, together they can contribute to a condition in which an embryo, fetus or newborn appears to be over-zealously fighting off a viral infection, but no causative pathogens are present. In people the disease is called Aicardi-Goutieres Syndrome.

While most babies with the mutation do not have symptoms, the severe forms of the condition can lead to cognitive impairment, additional neurological problems, and damage to other organs, like the kidneys and liver, and it can be fatal. While the two disorders are not considered related, the syndrome shares a few features with another autoimmune disease, systemic lupus erythematosus.

Because it looks like the baby is trying to overcome a virulent virus, but no actual infection can be detected, the disease appears to mimic an infection acquired just before or soon after birth.

Studying the immunological repercussions of this mutation, in addition to increasing critical knowledge to improve medical understanding about this devastating disease, can provide broader insights into some aspects of genetic and biochemical activities and interactions culminating in abnormal inflammation.

The findings of the research, conducted in mouse models, appear July 28 in the print edition of Nature. Here is the online copy of the paper. The study took place in the University of Washington School of Medicine immunology labs of Andrew Oberst, Daniel Stetson and Ram Savan. It was led by Nicholas W. Hubbard, Joshua M. Ames and Megan Maurano.

They learned that a point mutation in a particular domain of the ADAR1 gene can lead to the activation of a mammalian protein known as ZBP1. This protein can trigger programmed cell death and as well as the orchestration of other gene activities in a dramatic response to a supposed threat.

The scientists found that ablating ZBP1 got rid of the apparent damaging effects from the ADAR1 mutation without eliminating the mutation’s underlying inflammatory program. The loss of one of the genes involved in cell death also had some protective effects. However, the scientists were surprised to see that, if they deleted it along with several other enzymes involved in cell death, the multiple deletions paradoxically made matters worse.

These findings suggest that RNA from within our own cells is altered by ADAR1, and that when this does not happen normally the result is activation of ZBP1. Unexpectedly, the study found that the damage that results from this ZBP1 activation is not related to activating cell death, the previously described function of ZBP1. Rather, their study suggests that mutation of the ADAR1 gene allows ZBP1 to signal for inflammatory responses that make the body attack its own tissues, even though there are no pathogens present to encourage a fight to take place.

In addition, the results from this study also point to a dual function of the enzyme caspase-8 as both an agent of programmed cell death as well as a suppressor of ZBP1 cell death and inflammation.

“Indeed, both the presence and absence of caspase-8 may drive pathology in ADAR1-mutant mice,” the scientists wrote in their Nature paper. They scientists think that two different types of programmed cell self-destruction, as well as the production of inflammation signals, may all contribute. These could occur in varying degrees, depending on cell and tissue types, to cause organ damage in animals that carry the two genes associated with the autoimmune disease under investigation.

Source:

University of Washington School of Medicine/UW Medicine

Journal reference:

Hubbard, N.W., et al. (2022) ADAR1 mutation causes ZBP1-dependent immunopathology. Nature. doi.org/10.1038/s41586-022-04896-7.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

New molecule kills a broad spectrum of hard-to-treat cancers

by Medical Finance
August 13, 2022
0

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including...

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

by Medical Finance
August 13, 2022
0

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School...

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Eukaryotes emerged in a no-oxygen environment in the ocean, research suggests

by Medical Finance
August 13, 2022
0

The origin of complex cells started without oxygen, new research suggests. Since the 1960s, many experts have argued that the...

UW and Stanford researchers complete study on the link between food environment and dietary health

UW and Stanford researchers complete study on the link between food environment and dietary health

by Medical Finance
August 13, 2022
0

An estimated 19 million people in the U.S. live in so-called food deserts, which have lower access to healthy and...

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Contagious cancers can jump between marine clam species, study shows

by Medical Finance
August 13, 2022
0

A contagious blood cancer jumped from one species of clam to another and spread among clams living in the Atlantic...

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

by Medical Finance
August 13, 2022
0

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly...

Next Post
Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Study determines how genetics and environmental conditions interact during plant development

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Alcohol use decreases steadily among men, but problem drinking increases during the pandemic

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Artificially Colored MRI Scan Of Human Brain Daisy Daisy a8c5d8bbbf824bc8932308e30187510f 620x480
    Study reinforces the link between microglia and some cases of brain disease
  • Study: Humoral Response to The Third Dose Of SARS-Cov-2 Vaccine in Kidney Transplant Recipients. Image Credit: bluebay / Shutterstock.com
    Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply